Correlation of EGFRtyr1068 expression and EGFR inhibitor sensitivity was also found in commercial lung cancer cell lines, where EGFRtyr1068 was strictly associated with sensitivity regardless of EGFR mutational status. Here, EGFR is linked to lung carcinoma.